Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuele Buratti

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Expert Opinion on Therapeutic Targets|February 13, 2018
TDP-43 post-translational modifications in health and diseaseEmanuele Buratti
Neurology|September 30, 2011
TDP-43 and FUS in ALS/FTLD: will common pathways fit all?Emanuele Buratti
British Journal of Pharmacology|May 30, 2020
Targeting TDP-43 proteinopathy with drugs and drug-like small moleculesEmanuele Buratti
The EMBO Journal|June 12, 2016
The minor spliceosome could be the major key for FUS/TLS mutants in ALSEmanuele Buratti
Advances in Genetics|September 28, 2015
Functional Significance of TDP-43 Mutations in DiseaseEmanuele Buratti
Advances in Experimental Medicine and Biology|January 12, 2021
Trends in Understanding the Pathological Roles of TDP-43 and FUS ProteinsEmanuele Buratti
Genes|February 9, 2018
Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage DisordersAndrea Dardis, Emanuele Buratti
Journal of Neurochemistry|March 27, 2016
Physiological functions and pathobiology of TDP-43 and FUS/TLS proteinsAntonia Ratti, Emanuele Buratti
Micropublication Biology|July 31, 2024
tRNA <sup>Arg</sup> binds <i>in vitro</i> TDP-43 RNA recognition motifs and ligand of Ate1 protein LIAT1Ljiljana Sjekloća, Emanuele Buratti
Journal of Molecular Neuroscience : MN|June 18, 2011
TDP-43 autoregulation: implications for diseaseMauricio Budini, Emanuele Buratti
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Expert Opinion on Therapeutic Targets|February 13, 2018
TDP-43 post-translational modifications in health and diseaseEmanuele Buratti
Neurology|September 30, 2011
TDP-43 and FUS in ALS/FTLD: will common pathways fit all?Emanuele Buratti
British Journal of Pharmacology|May 30, 2020
Targeting TDP-43 proteinopathy with drugs and drug-like small moleculesEmanuele Buratti
The EMBO Journal|June 12, 2016
The minor spliceosome could be the major key for FUS/TLS mutants in ALSEmanuele Buratti
Advances in Genetics|September 28, 2015
Functional Significance of TDP-43 Mutations in DiseaseEmanuele Buratti
Advances in Experimental Medicine and Biology|January 12, 2021
Trends in Understanding the Pathological Roles of TDP-43 and FUS ProteinsEmanuele Buratti
Genes|February 9, 2018
Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage DisordersAndrea Dardis, Emanuele Buratti
Journal of Neurochemistry|March 27, 2016
Physiological functions and pathobiology of TDP-43 and FUS/TLS proteinsAntonia Ratti, Emanuele Buratti
Micropublication Biology|July 31, 2024
tRNA <sup>Arg</sup> binds <i>in vitro</i> TDP-43 RNA recognition motifs and ligand of Ate1 protein LIAT1Ljiljana Sjekloća, Emanuele Buratti
Journal of Molecular Neuroscience : MN|June 18, 2011
TDP-43 autoregulation: implications for diseaseMauricio Budini, Emanuele Buratti
Pageof 20